Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P E Fraser

Showing results (11-20 of 96) with videos related to

Pageof 10
Sort By:
Journal of Molecular Biology|June 6, 1997
Fibrillogenesis of Alzheimer Abeta peptides studied by fluorescence energy transferT H Huang, P E Fraser, A Chakrabartty
Biophysical Journal|February 1, 1993
Structure of beta-crystallite assemblies formed by Alzheimer beta-amyloid protein analogues: analysis by x-ray diffractionH Inouye, P E Fraser, D A Kirschner
Ciba Foundation Symposium|January 1, 1992
Aluminium and the pathogenesis of Alzheimer's disease: a summary of evidenceD R McLachlan, P E Fraser, A J Dalton
Biochemistry|October 29, 2000
Molecular structure of a fibrillar Alzheimer's A beta fragmentL C Serpell, C C Blake, P E Fraser
The Journal of Biological Chemistry|December 7, 2000
Amyloid-beta interactions with chondroitin sulfate-derived monosaccharides and disaccharides. implications for drug developmentP E Fraser, A A Darabie, J A McLaurin
Journal of Molecular Biology|May 26, 1998
Phosphatidylinositol and inositol involvement in Alzheimer amyloid-beta fibril growth and arrestJ McLaurin, T Franklin, A Chakrabartty, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1993
A kinetic model for amyloid formation in the prion diseases: importance of seedingJ H Come, P E Fraser, P T Lansbury
The Journal of Biological Chemistry|March 21, 1998
Structural transitions associated with the interaction of Alzheimer beta-amyloid peptides with gangliosidesJ McLaurin, T Franklin, P E Fraser, et al.
Biochimica Et Biophysica Acta|July 24, 1989
Bilayer-stabilizing properties of myelin basic protein in dioleoylphosphatidylethanolamine systemsP E Fraser, R P Rand, C M Deber
Drug News & Perspectives|August 26, 2003
Neuropathological, biochemical and genetic alterations in ADP H St George-Hyslop, J McLaurin, P E Fraser
Pageof 10

Showing results (11-20 of 96) with videos related to

Sort By:
Pageof 10
Journal of Molecular Biology|June 6, 1997
Fibrillogenesis of Alzheimer Abeta peptides studied by fluorescence energy transferT H Huang, P E Fraser, A Chakrabartty
Biophysical Journal|February 1, 1993
Structure of beta-crystallite assemblies formed by Alzheimer beta-amyloid protein analogues: analysis by x-ray diffractionH Inouye, P E Fraser, D A Kirschner
Ciba Foundation Symposium|January 1, 1992
Aluminium and the pathogenesis of Alzheimer's disease: a summary of evidenceD R McLachlan, P E Fraser, A J Dalton
Biochemistry|October 29, 2000
Molecular structure of a fibrillar Alzheimer's A beta fragmentL C Serpell, C C Blake, P E Fraser
The Journal of Biological Chemistry|December 7, 2000
Amyloid-beta interactions with chondroitin sulfate-derived monosaccharides and disaccharides. implications for drug developmentP E Fraser, A A Darabie, J A McLaurin
Journal of Molecular Biology|May 26, 1998
Phosphatidylinositol and inositol involvement in Alzheimer amyloid-beta fibril growth and arrestJ McLaurin, T Franklin, A Chakrabartty, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1993
A kinetic model for amyloid formation in the prion diseases: importance of seedingJ H Come, P E Fraser, P T Lansbury
The Journal of Biological Chemistry|March 21, 1998
Structural transitions associated with the interaction of Alzheimer beta-amyloid peptides with gangliosidesJ McLaurin, T Franklin, P E Fraser, et al.
Biochimica Et Biophysica Acta|July 24, 1989
Bilayer-stabilizing properties of myelin basic protein in dioleoylphosphatidylethanolamine systemsP E Fraser, R P Rand, C M Deber
Drug News & Perspectives|August 26, 2003
Neuropathological, biochemical and genetic alterations in ADP H St George-Hyslop, J McLaurin, P E Fraser
Pageof 10